However, cardiovascular diseases remain the primary cause of death in MAFLD patients, and individuals with MAFLD are at ...

A new study finds that obesity significantly reduces the effectiveness of urate-lowering therapy in male gout patients, with ...

Expand your understanding of cardiovascular (CV) health in women experiencing menopause, and stay ahead of developments in ...

A new study finds no significant overall association between hormone therapy use and glioma risk in US women, although a ...

IC31 did not reduce the risk of recurrent disease in individuals who completed treatment for pulmonary tuberculosis.

A new study finds that ursodeoxycholic acid (UDCA) effectively dissolves gallstones in 60% of patients after sleeve ...

Bradley Monk shares key insights and breakthroughs in gynaecologic oncology from ESGO 2025, shaping cancer care's future.

ATOPIC dermatitis (AD) is a chronic inflammatory skin condition that significantly impacts patients’ quality of life. It is ...

A phase 3 trial confirms delgocitinib cream is safe and effective for long-term treatment of chronic hand eczema, maintaining disease control for up to 52 weeks.

Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...

A major meta-analysis of 1.3 million patients confirms remdesivir improves COVID-19 survival. But are treatment guidelines keeping up with the evidence?